ArticleClinical drug investigation2017

Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece.

George Gourzoulidis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.